home / stock / prct / prct news


PRCT News and Press, PROCEPT BioRobotics Corporation From 03/24/22

Stock Information

Company Name: PROCEPT BioRobotics Corporation
Stock Symbol: PRCT
Market: NASDAQ
Website: procept-biorobotics.com

Menu

PRCT PRCT Quote PRCT Short PRCT News PRCT Articles PRCT Message Board
Get PRCT Alerts

News, Short Squeeze, Breakout and More Instantly...

PRCT - Tracking Stanley Druckenmiller's Duquesne Family Office Portfolio - Q4 2021 Update

Stanley Druckenmiller’s 13F portfolio value decreased from $3.08B to $2.76B this quarter. Duquesne increased Coupang, Carvana, Kbr, Flex, Procept Bio, and Smartsheet while decreasing Alphabet, Amazon.com, Palo Alto Networks, Starbucks, and Expedia Group. They also dropped Meta ...

PRCT - Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q4 2021 Update

Halvorsen's 13F portfolio value decreased from $36.04B to $34.49B this quarter. The number of positions increased from 96 to 107. Viking Global added Twilio, Workday, and Aon plc while dropping Fidelity National Information Services and Snowflake. The top three positions are Ginkg...

PRCT - PROCEPT BioRobotics Corporation (PRCT) Q4 2021 Earnings Call Transcript

Image source: The Motley Fool. PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Q4 2021 Earnings Call Mar 08, 2022 , 8:00 a.m. ET Operator Continue reading For further details see: PROCEPT BioRobotics Corporation (PRCT) Q4 2021 Earnings Cal...

PRCT - Procept BioRobotics spikes as guidance tops estimates

The shares of Procept BioRobotics(PRCT +4.8%) have recorded the second biggest intraday gain on Tuesday after the surgical robotics company issued better-than-expected guidance for 2022 and the current quarter. Revenue for Q4 and full-year 2021 climbed ~216% YoY and ~348% YoY to $10.1M and $3...

PRCT - PROCEPT BioRobotics (PRCT) CEO Reza Zadno on Q4 2021 Results - Earnings Call Transcript

PROCEPT BioRobotics (PRCT) Q4 2021 Earnings Conference Call March 8, 2022, 8:00 AM ET Company Participants Reza Zadno – Chief Executive Officer Matt Bacso – Gilmartin Group Kevin Waters – Chief Financial Officer Conference Call Participants Craig Bijou – Bank of Am...

PRCT - Procept GAAP EPS of -$0.42 misses by $0.03, revenue of $10.14M beats by $0.76M

Procept press release (NASDAQ:PRCT): Q4 GAAP EPS of -$0.42 misses by $0.03. Revenue of $10.14M (+214.9% Y/Y) beats by $0.76M. For further details see: Procept GAAP EPS of -$0.42 misses by $0.03, revenue of $10.14M beats by $0.76M

PRCT - PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2021 Financial Results

REDWOOD CITY, Calif., March 08, 2022 (GLOBE NEWSWIRE) -- PROCEPT ® BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported financial results for the...

PRCT - PROCEPT BioRobotics Corp. to Report Fourth Quarter and Full Year 2021 Financial Results on March 8, 2022

REDWOOD CITY, Calif., Feb. 22, 2022 (GLOBE NEWSWIRE) -- PROCEPT ® BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it will report finical results for the four...

PRCT - Druckenmiller's Duquesne adds Willscot Mobile Mini, exits Nektar Therapeutics

Stanley Druckenmiller's Duquesne Family Office takes new positions in WillScot Mobile Mini Holdings (NASDAQ:WSC) with a 1.50M stake, Snap (NYSE:SNAP) with 1.44M shares, and Chevron with 824K shares, according to the firm's latest 13F. It exited Nektar Therapeutics (NASDAQ:NKTR), Farfetch (NYS...

PRCT - PROCEPT Announces 5-Year WATER Study Data Comparing Aquablation to TURP

– Symptom reduction and uroflow improvement proved durable and consistent compared to TURP – Larger prostates (≥50 ml) demonstrated a larger safety and efficacy benefit for Aquablation over TURP – 5-year Aquablation retreatment rate wa...

Previous 10 Next 10